Clinical trialsOfficial
Olympus updates reprocessing instructions for GF-UC140P-AL5 endoscopic ultrasound gastrovideoscopes in Canada
🇨🇦 Health Canada · Thu 19 Nov 2026
Health Canada lists a Type II recall of Olympus ultrasonic gastrovideoscopes for Aloka processors, with revised manual reprocessing instructions and training for customers.
Health Canada has published a Type II recall covering the Olympus Endoscopic Ultrasound System and Olympus Ultrasonic Gastrovideoscopes for Aloka Ultrasound Processors. The notice was posted on 19 November 2026 under identification number RA-82980. The recall date is given as 6 November 2026.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Official source: Health Canada ↗
Article written by VigiEye from the official source (Health Canada). AI-assisted; check the source before acting.
More Clinical trials
All →
PMV Pharma reports 48% response rate for rezatapopt in platinum-resistant ovarian cancer
🇺🇸 PMV Pharmaceuticals, Inc. (PMVP) · Fri 20 Nov 2026
J&J's Tremfya beats placebo in Phase 4 STAR axial psoriatic arthritis study at Week 24
Johnson & Johnson EMEA · Fri 20 Nov 2026
Immutep reports 81% 12-month disease-free survival in neoadjuvant soft tissue sarcoma trial
IMMUTEP Ltd (IMMP) · Fri 20 Nov 2026
BfArM lists ArcRoyal field safety notice for procedure trays containing BD Connecta Stopcock
🇩🇪 BfArM field safety notices · Thu 19 Nov 2026
FDA allows Alpha Tau to double REGAIN glioblastoma trial to 20 patients
Alpha Tau Medical Ltd. (DRTS) · Thu 19 Nov 2026
Health Canada posts Type II recall of Philips Bridge Prep Kit over guidewire resistance
🇨🇦 Health Canada · Thu 19 Nov 2026